An alternative medicine, Agaricus blazei, may have induced severe hepatic dysfunction in cancer patients

Japanese Journal of Clinical Oncology

Volumn 36, Issue 12, 2006, Pages 808-810

  Mukai, Hirofumi ^a   Watanabe, Toru ^b   Ando, Masashi ^c   Katsumata, Noriyuki ^c  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b Hamamatsu Oncology Center   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Agaricus blazei; Alternative medicine; Fulminant hepatitis

Indexed keywords

AGARICUS BLAZEI EXTRACT; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; VIRUS DNA; PLANT EXTRACT;

ACUTE HEPATITIS; ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ALTERNATIVE MEDICINE; ANOREXIA; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER PATIENT; CANCER STAGING; CASE REPORT; COMBINATION CHEMOTHERAPY; CONSCIOUSNESS; DEATH; DISEASE SEVERITY; DRUG FATALITY; DRUG FEVER; DRUG WITHDRAWAL; FATIGUE; FEMALE; HEPATITIS; HEPATITIS B VIRUS; HOSPITAL ADMISSION; HUMAN; LIVER DYSFUNCTION; MASTECTOMY; MEDICAL DECISION MAKING; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; OVARY CANCER; POLYMERASE CHAIN REACTION; PROTHROMBIN TIME; SEROLOGY; SIDE EFFECT; VIRUS CARRIER; VIRUS REPLICATION; AGARICUS; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FATALITY; LIVER; LIVER DISEASE; LIVER FUNCTION TEST; MIDDLE AGED; OVARY TUMOR; PATHOLOGY; PHYTOTHERAPY;

AGARICUS; AGED; BREAST NEOPLASMS; COMPLEMENTARY THERAPIES; FATAL OUTCOME; FEMALE; HUMANS; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS; MIDDLE AGED; OVARIAN NEOPLASMS; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 33947523663     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyl108     Document Type: Article

References (14)

1. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 1993;328:246-52.
2. Fernandez CV, Stutzer CA, MacWilliam L, Fryer C. Alternative and complementary therapy use in pediatric oncology patients in British Columbia: Prevalence and reasons for use and nonuse. J Clin Oncol 1988;16:1279-86.
3. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al.. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998;280:1569-75.
4. Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med 2000;342:1266-71.
5. Durant JR. Alternative medicine: An attractive nuisance. J Clin Oncol 1998;16:1-2.
6. Labriola D, Livingston R. Possible interactions between dietary antioxidants and chemotherapy. Oncology (Williston Park) 1999;13:1003-8; discussion 1008, 11-12.
7. Faggioli P, De Paschale M, Tocci A, Luoni M, Fava S, De Paoli A, et al. Acute hepatic toxicity during cyclic chemotherapy in non Hodgkin's lymphoma. Haematologica 1997;82:38-42.
8. Sato T, Kato J, Kawanishi J, Kogawa K, Ohya M, Sakamaki S, et al. Acute exacerbation of hepatitis due to reactivation of hepatitis B virus with mutations in the core region after chemotherapy for malignant lymphoma. J Gastroenterol 1997;32:668-71.
9. Cassileth BR. Complementary and alternative cancer medicine. J Clin Oncol 1999;17:44-52.
10. DiPaola RS, Zhang H, Lambert GH, Meeker R, Licitra E, Rafi MM, et al. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. N Engl J Med 1998;339:785-91.
11. Lerner IJ, Kennedy BJ. The prevalence of questionable methods of cancer treatment in the United States. CA Cancer J Clin 1992;42:181-91.
12. Metz JM, Jones H, Devine P, Hahn S, Glatstein E. Cancer patients use unconventional medical therapies far more frequently than standard history and physical examination suggest. Cancer J 2001;7:149-54.
13. Cassileth BR, Lusk EJ, Strouse TB, Bodenheimer BJ. Contemporary unorthodox treatments in cancer medicine. A study of patients, treatments, and practitioners. Ann Intern Med 1984;101:105-12.
14. Miller DR, Anderson GT, Stark JJ, Granick JL, Richardson D. Phase I/II trial of the safety and efficacy ot shark cartilage in the treatment of advanced cancer. J Clin Oncol 1998;16:3649-55.